-
21
Clozapine responsive catatonia: A series of five cases
Published 2012-01-01Subjects: Get full text
Article -
22
Catatonia and melancholia interface: exploring a new paradigm for evaluation and treatment. A case series and literature review
Published 2024-03-01Subjects: Get full text
Article -
23
-
24
Differentiating anxiety from fear: an experimental–pharmacological approach
Published 2020-01-01Subjects: Get full text
Article -
25
-
26
The anti-anxiety drug lorazepam changes implicit behaviors but not explicit evaluations of sense of agency under authoritative pressure: A functional magnetic resonance imaging study
Published 2022-11-01Subjects: “…lorazepam…”
Get full text
Article -
27
-
28
Missed Diagnosis of Major Depressive Disorder with Catatonia Features
Published 2019-02-01Subjects: Get full text
Article -
29
Activated Carbon-Based System for the Disposal of Psychoactive Medications
Published 2016-11-01Subjects: “…lorazepam…”
Get full text
Article -
30
Voltammetric Electronic Tongue for the Simultaneous Determination of Three Benzodiazepines
Published 2019-11-01Subjects: Get full text
Article -
31
Successful Treatment of Irinotecan-Induced Muscle Twitching: A Case Report
Published 2023-01-01“…Benzodiazepine agonists, such as lorazepam, is the potential treatment of choice.…”
Get full text
Article -
32
Catatonia, Pregnancy, and Electroconvulsive Therapy (ECT)
Published 2023-01-01“…While initially, the patient appeared to have a positive response to lorazepam, she became increasingly catatonic with minimal oral intake, mutism, and urinary retention. …”
Get full text
Article -
33
Negative emotionality downregulation affects moral choice but not moral judgement of harm: a pharmacological study
Published 2024-01-01“…Furthermore, using another sample (Study 2, N = 31), we assess whether lorazepam’s effect is modulated by different perspective-taking conditions during a moral dilemma task –e.g. …”
Get full text
Article -
34
Management and outcomes of catatonia: A prospective study in urban South Africa
Published 2022-06-01“…Treatment guidelines for catatonia need to include the role and timing of electroconvulsive therapy to augment current treatment protocols for the use of lorazepam.…”
Get full text
Article -
35
Jasmine essential oil promotes delta-beta power activities in the dorsal hippocampus under slow wave sleep promotion
Published 2023-02-01“…Adult male Swiss Albino (ICR) mice treated with distilled water, jasmine essential oil and lorazepam administration were assessed for sleep stages offline from the dorsal hippocampal brain activity. …”
Get full text
Article -
36
Assessment of Treatment Patterns in Patients with Alcohol Withdrawal Syndrome during Hospitalisation and Post-discharge: A Retrospective Cohort Study
Published 2023-09-01“…During post-discharge treatment, 57.0% (n/N=74/130) of patients received lorazepam, while 52.0% (n/N=67/130) received chlordiazepoxide. …”
Get full text
Article -
37
An Emulation of Randomized Trials of Administrating Benzodiazepines in PTSD Patients for Outcomes of Suicide-Related Events
Published 2020-10-01“…Head-to-head comparisons identified that patients who received alprazolam had fewer SRBs compared to clonazepam (<i>p</i> = 0.0351) and lorazepam (<i>p</i> = 0.0373), and patients taking midazolam experienced fewer relative incidences of SRBs when compared to lorazepam (<i>p</i> = 0.0021) and clonazepam (<i>p</i> = 0.0297). …”
Get full text
Article -
38
A rare case of recurrent psychosis with hypothyroidism precipitating catatonia
Published 2023-01-01“…After being diagnosed with catatonia, 2 mg of lorazepam was administered intravenously, and after 10 min, she began speaking. …”
Get full text
Article -
39
Catatonia as a Result of a Traumatic Brain Injury
Published 2024-01-01“…After being admitted with the diagnosis of postconcussive syndrome, he was ultimately diagnosed with catatonia, and intravenous lorazepam resulted in a return to his baseline mental status. …”
Get full text
Article -
40
5HT-3 RECEPTOR BLOCKADE IN NICOTINE WITHDRAWAL - STUDY WITH BRL 46470A
Published 1993“…The study was of a double-blind, placebo-controlled, four-way crossover design using two doses of BRL 46470A (0.1 and 10 μg) and one dose of lorazepam (1 mg). Outcome measures included visual analogue ratings for nicotine withdrawal and a battery of psychological performance tests. …”
Journal article